Fresenius Kabi Oncology Ltd
Fresenius Kabi Oncology Ltd (FKONCO): company summary
Fresenius Kabi Oncology Ltd (FKONCO) is an Indian listed company operating in Pharmaceuticals & Biotechnology on the NSE and BSE.
Fresenius Kabi Oncology Ltd (FKONCO) is an Indian listed company operating in Pharmaceuticals & Biotechnology on the NSE and BSE.
- Financial performance
- Revenue has been growing steadily at 6.8% a year over three years. Return on equity is 11.2%.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Held back by risk (0.3). The latest financials on file are more than 18 months old, so treat the fundamental measures with caution. Scored on 3 of 5 measures.
DocStoX score
Low confidenceScored on 3 of 5 measures — the rest have no data for this company.
At a glance
Key highlights
- Loss-making in some of the last 5 years
- Quality is weak (1.4/10)
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals & Biotechnology
Explore Fresenius Kabi Oncology Ltd’s valuation
Free deep-dive tools · no sign-up
Fresenius Kabi Oncology Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Compare Fresenius Kabi Oncology Ltd with peers
Related tools & concepts
Value Fresenius Kabi Oncology Ltd with the ratios and calculators DocStoX uses in its analysis.

